Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NCT04851119

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +90 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 21 locations
View Trial Details
Recruiting

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

NCT06413680

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +28 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
  • Yale School of Medicine North Haven, Connecticut, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Recruiting

Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer

NCT05522660

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations
  • Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" Naples, Italy
  • Instituto Oncologico Veneto IRCCS Padova, Italy
  • Santa Maria della Misericordia Hospital Perugia, Italy
  • Istituto Nazionale Tumori "Regina Elena" Roma, Italy
View all 15 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

NCT06326411

Conditions
Glioma, MAPK Pathway Gene Mutation, MEK Mutation, +19 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • UCLA Hematology/Oncology Westwood, Los Angeles, California, United States
  • Sarah Cannon Research Institute at Health ONE Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 23 locations
View Trial Details
Recruiting

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

NCT06362369

Conditions
ALK Genomic Tumor Aberrations, Adenocarcinoma, Adenoma, +69 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
  • Dartmouth Hitchcock Lebanon, New Hampshire, United States
  • Brown University Health Cancer Institute Providence, Rhode Island, United States
View Trial Details

Related conditions